Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,022
Closed -$4.62K 2105
2025
Q4
$4.62K Hold
1,022
﹤0.01% 995
2025
Q3
$5.51K Hold
1,022
﹤0.01% 898
2025
Q2
$5.55K Hold
1,022
﹤0.01% 766
2025
Q1
$2.83K Hold
1,022
﹤0.01% 815
2024
Q4
$3.49K Buy
+1,022
New +$2.95K ﹤0.01% 780

Physician Wealth Advisors's CVAC Position: Q1 2026 in Review

Physician Wealth Advisors sold out of CureVac (CVAC) in Q1 2026, closing a stake of 1,022 shares — an estimated $4.62K sold.

Physician Wealth Advisors first reported a position in CVAC in Q4 2024 and held it in 5 quarters. The position peaked at $5.55K in Q2 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Physician Wealth Advisors reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Physician Wealth Advisors sold 1,022 CureVac shares in Q1 2026, an estimated $4.62K.
  • Physician Wealth Advisors first reported a position in CureVac in Q4 2024 and held it in 5 quarters.
  • Physician Wealth Advisors's CureVac position peaked at $5.55K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.